StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) from a sell rating to a hold rating in a report issued on Tuesday morning.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 22nd Century Group in a research note on Saturday, March 22nd.
Read Our Latest Report on 22nd Century Group
22nd Century Group Trading Up 4.9 %
Institutional Inflows and Outflows
An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP acquired a new stake in 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned approximately 6.77% of 22nd Century Group at the end of the most recent quarter. Hedge funds and other institutional investors own 18.06% of the company’s stock.
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- Stock Sentiment Analysis: How it Works
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.